Cargando…
Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
BACKGROUND: Despite the widely recognized association between the severity of early preterm birth (ePTB) and its related severe diseases, little is known about the potential risk factors of ePTB and the sub-population with high risk of ePTB. Moreover, motivated by a future confirmatory clinical tria...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223445/ https://www.ncbi.nlm.nih.gov/pubmed/28068927 http://dx.doi.org/10.1186/s12884-016-1189-0 |
_version_ | 1782493173600223232 |
---|---|
author | Zhang, Chuanwu Garrard, Lili Keighley, John Carlson, Susan Gajewski, Byron |
author_facet | Zhang, Chuanwu Garrard, Lili Keighley, John Carlson, Susan Gajewski, Byron |
author_sort | Zhang, Chuanwu |
collection | PubMed |
description | BACKGROUND: Despite the widely recognized association between the severity of early preterm birth (ePTB) and its related severe diseases, little is known about the potential risk factors of ePTB and the sub-population with high risk of ePTB. Moreover, motivated by a future confirmatory clinical trial to identify whether supplementing pregnant women with docosahexaenoic acid (DHA) has a different effect on the risk subgroup population or not in terms of ePTB prevalence, this study aims to identify potential risk subgroups and risk factors for ePTB, defined as babies born less than 34 weeks of gestation. METHODS: The analysis data (N = 3,994,872) were obtained from CDC and NCHS’ 2014 Natality public data file. The sample was split into independent training and validation cohorts for model generation and model assessment, respectively. Logistic regression and CART models were used to examine potential ePTB risk predictors and their interactions, including mothers’ age, nativity, race, Hispanic origin, marital status, education, pre-pregnancy smoking status, pre-pregnancy BMI, pre-pregnancy diabetes status, pre-pregnancy hypertension status, previous preterm birth status, infertility treatment usage status, fertility enhancing drug usage status, and delivery payment source. RESULTS: Both logistic regression models with either 14 or 10 ePTB risk factors produced the same C-index (0.646) based on the training cohort. The C-index of the logistic regression model based on 10 predictors was 0.645 for the validation cohort. Both C-indexes indicated a good discrimination and acceptable model fit. The CART model identified preterm birth history and race as the most important risk factors, and revealed that the subgroup with a preterm birth history and a race designation as Black had the highest risk for ePTB. The c-index and misclassification rate were 0.579 and 0.034 for the training cohort, and 0.578 and 0.034 for the validation cohort, respectively. CONCLUSIONS: This study revealed 14 maternal characteristic variables that reliably identified risk for ePTB through either logistic regression model and/or a CART model. Moreover, both models efficiently identify risk subgroups for further enrichment clinical trial design. |
format | Online Article Text |
id | pubmed-5223445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52234452017-01-11 Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design Zhang, Chuanwu Garrard, Lili Keighley, John Carlson, Susan Gajewski, Byron BMC Pregnancy Childbirth Research Article BACKGROUND: Despite the widely recognized association between the severity of early preterm birth (ePTB) and its related severe diseases, little is known about the potential risk factors of ePTB and the sub-population with high risk of ePTB. Moreover, motivated by a future confirmatory clinical trial to identify whether supplementing pregnant women with docosahexaenoic acid (DHA) has a different effect on the risk subgroup population or not in terms of ePTB prevalence, this study aims to identify potential risk subgroups and risk factors for ePTB, defined as babies born less than 34 weeks of gestation. METHODS: The analysis data (N = 3,994,872) were obtained from CDC and NCHS’ 2014 Natality public data file. The sample was split into independent training and validation cohorts for model generation and model assessment, respectively. Logistic regression and CART models were used to examine potential ePTB risk predictors and their interactions, including mothers’ age, nativity, race, Hispanic origin, marital status, education, pre-pregnancy smoking status, pre-pregnancy BMI, pre-pregnancy diabetes status, pre-pregnancy hypertension status, previous preterm birth status, infertility treatment usage status, fertility enhancing drug usage status, and delivery payment source. RESULTS: Both logistic regression models with either 14 or 10 ePTB risk factors produced the same C-index (0.646) based on the training cohort. The C-index of the logistic regression model based on 10 predictors was 0.645 for the validation cohort. Both C-indexes indicated a good discrimination and acceptable model fit. The CART model identified preterm birth history and race as the most important risk factors, and revealed that the subgroup with a preterm birth history and a race designation as Black had the highest risk for ePTB. The c-index and misclassification rate were 0.579 and 0.034 for the training cohort, and 0.578 and 0.034 for the validation cohort, respectively. CONCLUSIONS: This study revealed 14 maternal characteristic variables that reliably identified risk for ePTB through either logistic regression model and/or a CART model. Moreover, both models efficiently identify risk subgroups for further enrichment clinical trial design. BioMed Central 2017-01-10 /pmc/articles/PMC5223445/ /pubmed/28068927 http://dx.doi.org/10.1186/s12884-016-1189-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zhang, Chuanwu Garrard, Lili Keighley, John Carlson, Susan Gajewski, Byron Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design |
title | Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design |
title_full | Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design |
title_fullStr | Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design |
title_full_unstemmed | Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design |
title_short | Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design |
title_sort | subgroup identification of early preterm birth (eptb): informing a future prospective enrichment clinical trial design |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223445/ https://www.ncbi.nlm.nih.gov/pubmed/28068927 http://dx.doi.org/10.1186/s12884-016-1189-0 |
work_keys_str_mv | AT zhangchuanwu subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign AT garrardlili subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign AT keighleyjohn subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign AT carlsonsusan subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign AT gajewskibyron subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign |